Everything is tailored to the patient
SGLT2 Inhibitors, both classes deliver strong outcomes but in distinct ways
Compared with untreated individuals, those receiving GLP-1 therapy showed lower levels of pro-inflammatory cytokines (IL-6, TNF-, IL-12), higher levels of IL-10, reduced expression of endothelial adhesion molecules (ICAM-1, VCAM-1), and decreased leukocyte rolling and adhesion along the vascular endothelium [15]
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) slow gastric emptying and commonly cause nausea, vomiting, and diarrhoea, particularly during treatment initiation
In some cases, health insurance plans provide coverage for GLP-1 medications
The single dose pens come with an attached needle and do not require any assembly prior to use